140 related articles for article (PubMed ID: 6186997)
1. [Results of treatment of the lymphoblastic and immunoblastic malignant lymphomas using the CHOP-bleo protocol (cyclophosphamide, doxorubicin, vincristine, bleomycin and prednisolone)].
Płuzańska A; Kowalczyński M; Polkowska E; Stempczyńska J; Hyjek E
Pol Arch Med Wewn; 1982; 68(1-2):55-64. PubMed ID: 6186997
[No Abstract] [Full Text] [Related]
2. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E
Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105
[No Abstract] [Full Text] [Related]
3. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
4. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas.
Kaku K; Inoue M; Fujii S; Ishida Y; Hiroshige Y; Shinohara K; Nakashima K; Matsumoto N; Kaneko T
Nihon Ketsueki Gakkai Zasshi; 1983 Jul; 46(4):940-6. PubMed ID: 6195877
[No Abstract] [Full Text] [Related]
5. A ten-year update of CHOP-BLEO in the treatment of diffuse large-cell lymphoma.
Hryniuk WM
J Clin Oncol; 1987 Apr; 5(4):682. PubMed ID: 2435859
[No Abstract] [Full Text] [Related]
6. Diffuse large-cell lymphoma: more CHOP-Bleo is not better.
Coltman CA
J Clin Oncol; 1986 Oct; 4(10):1439-40. PubMed ID: 2428946
[No Abstract] [Full Text] [Related]
7. [Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients].
González Brito G; Marsá Vilá L; Chávez MI; Batista López N; Hernández Nieto L
Sangre (Barc); 1985; 30(3):367-8. PubMed ID: 2412301
[No Abstract] [Full Text] [Related]
8. [Induction of remission in patients with non-Hodgkin lymphomas with high degree of malignancy - preliminary comparison of 2 chemotherapy programs: CHOP-B (cyclophosphamide, adriamycin, vincristine, encorton, bleomycin) and MEV-A (methotrexate, cyclophosphamide, vincristine and adriamycin)].
Walewski JA
Nowotwory; 1983; 33(3):259-65. PubMed ID: 6198637
[No Abstract] [Full Text] [Related]
9. [Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation].
Płuzańska A; Małecka E; Krykowski E; Olszańska-Skorek T; Stempczyńska J; Polkowska E; Hyjek E
Pol Arch Med Wewn; 1988 Dec; 80(6):323-30. PubMed ID: 2481844
[No Abstract] [Full Text] [Related]
10. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
Lee R; Cabanillas F; Bodey GP; Freireich EJ
J Clin Oncol; 1986 Oct; 4(10):1455-61. PubMed ID: 2428947
[TBL] [Abstract][Full Text] [Related]
11. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
Case DC
Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
14. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
15. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
Coiffier B; Bryon PA; Berger F; Archimbaud E; Ffrench M; Extra JM; Guyotat D; Fiere D; Gentilhomme O; Magaud JP
J Clin Oncol; 1986 Feb; 4(2):147-53. PubMed ID: 2418166
[TBL] [Abstract][Full Text] [Related]
16. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma: a single-institutional study with a long-term follow-up.
Ohnoshi T; Hayashi K; Ueno K; Tada A; Mizuta J; Tagawa S; Matsutomo S; Saito S; Kawashima K; Yoshino T
Int J Hematol; 1993 Aug; 58(1-2):93-8. PubMed ID: 7693030
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy in advanced non-Hodgkin's lymphoma: follow-up studies].
Kimura I
Nihon Rinsho; 1983 Nov; 41(11):2600-10. PubMed ID: 6200629
[No Abstract] [Full Text] [Related]
19. [Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].
Coiffier B; Bryon PA; Fière D; Felman P; Ffrench M; Rebattu P; Archimbaud E; Blanc M; Vuvan H; Guyotat D
Presse Med; 1983 Oct; 12(35):2159-62. PubMed ID: 6195654
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy in advanced malignant lymphoma with bleomycin, vincristine, adriamycin and prednisolone (author's transl)].
Kurita S; Kamei Y; Murakami M; Oyama A; Goto T; Fukushima M; Ota K
Rinsho Ketsueki; 1982 Jan; 23(1):61-7. PubMed ID: 6178855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
